What is iBio's market cap?

iBio is currently worth $ 328.99 M

How many employees does iBio have globally?

iBio has 1-50 employees worldwide.

What kind of company is iBio?

iBio develops and offers product applications of its iBioLaunch™ and iBioModulator™ platforms, providing collaborators full support for turn-key implementation ...

What is iBio's official website?

iBio's official website is http://www.ibioinc.com.

Who is the founder of iBio?

iBio was founded by Robert B. Kay.

Where is iBio's headquarters?

iBio is located in United States, Delaware.

Where are iBio offices?

iBio has offices in California,United States and in 1 other locations.

Who are iBio key executives?

iBio 's key executives are Robert B. Kay; Thomas F. Isett; Robert B. Kay

Who are iBio competitors?

Competitors of iBio include Pfizer; Takeda Pharmaceutical

iBio, Inc.:Company Profile & Technical Research,Competitor Monitor,Market Trends - Discovery

Q: What is iBio's industry?

iBiois in the industry of: Pharmaceutical and Medicine Manufacturing, Software Publishers

Q: What technical fields has iBio researched?

iBio has researched the technical fields related to Medicine, Pharmacy and Therapeutics, Robotics, Surge Capacity, Remedial action, Monoclonal antibody, Therapeutic protein, Drug development, Coronavirus disease 2019 (COVID-19), Drug discovery, Infection drug, Gene, Coronavirus, Systemic scleroderma, Fever drug, Cardiovascular agent, Biotechnology, Clinical trial, Biomedicine, C1-inhibitor

Free Trial

Basic Info

Headquarter

Delaware, United States

Founded Year

2008

Employees

< 10

Stock Symbol

NYSEAMERICAN: IBIO

Social Media

http://www.ibioinc.com

iBio is a company that provides Medicine, Pharmacy and Therapeutics, Robotics and more. iBio is headquartered in United States Delaware. iBio was founded in 2008. and was founded by Robert B. Kay. iBio has a total of 115 patents

Data Snapshot

115

Patent

Funding

USD 2.37 M

Revenue

434

News

Acquisition

Investment

Innovation Word Cloud

Analysis include all subsidiaries

A quick overview of tech portfolio with the top keywords and phrases extracted from patents of iBio

OverallRecent 3 years

Download

High Related Markets

Mentioned companies in the market reports of major market categories and sectors by iBio

Market Category

Pharmaceuticals

Healthcare

Market Segment

Infectious Diseases Drugs

Immune Disorders Drugs

Liver and Kidney Disorders Drugs

Diagnostics

Related Company

Related Market Sectors

Innovation Matrix

Analysis include all subsidiaries

visualizing technology portfolio of hot application areas and blank areas for iBio

All PatentsActive PatentsInactive PatentsPending Patents

Time Range:

Download

Subsidiary Lists

Subsidiaries with patent applications for iBio

Company

STARTUP

RubrYc Therapeutics, Inc.

United States California

Topics

Health carePharmacy and TherapeuticsAntibody[+5]

Patents

iBio Frequently Asked Questions

What is iBio's industry?

iBio is in the industry of: Pharmaceutical and Medicine ManufacturingSoftware Publishers

What technical fields has iBio researched?

iBio has researched the technical fields related to MedicinePharmacy and TherapeuticsRoboticsSurge CapacityRemedial actionMonoclonal antibodyTherapeutic proteinDrug developmentCoronavirus disease 2019 (COVID-19)Drug discoveryInfection drugGeneCoronavirusSystemic sclerodermaFever drugCardiovascular agentBiotechnologyClinical trialBiomedicineC1-inhibitor